학술논문
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation
Original Article
Original Article
Document Type
Clinical report
Author
Source
The New England Journal of Medicine. Oct 29, 2020, Vol. 383 Issue 18, p1735, 11 p.
Subject
Language
English
ISSN
0028-4793
Abstract
The efficacy and safety of edoxaban for nonvalvular atrial fibrillation among elderly patients are examined. A once-a-day 15-milligram dose of edoxaban was more effective than placebo in preventing stroke or systemic embolism.